About Scandbio
Scandbio was founded in 2016 in Jönköping, Sweden, within the biotechnology sector. Plant-derived products, including pharmaceuticals and health supplements, are researched, developed, and produced to address health issues like pain management and immune support. Operations emphasize novel medication innovation from natural sources. Quality and safety standards are prioritized throughout manufacturing. The companys domain, scandbio.com, supports its activities in this field.
- Headquarter Jonkoping, Sweden
-
Sectors
Energy & Utilities
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Scandbio Ab
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Scandbio
Detailed funding history for Scandbio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Scandbio
Scandbio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LEAG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Non-renewable energy power projects are developed in Germany.
|
Locked | Locked | Locked |
Investor details for Scandbio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Scandbio
Investment portfolio details for Scandbio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Scandbio
Detailed financials for Scandbio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scandbio Comparisons
Peer comparison for Scandbio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scandbio
Detailed competitors of Scandbio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scandbio
Complete news archive for Scandbio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scandbio
Scandbio was founded in 2016.
Scandbio is headquartered in Jonkoping, Sweden. It is registered at Jonkoping, Jonkoping County, Sweden.
Scandbio was founded in 2016 in Jönköping, Sweden, within the biotechnology sector. Plant-derived products, including pharmaceuticals and health supplements, are researched, developed, and produced to address health issues like pain management and immune support. Operations emphasize novel medication innovation from natural sources. Quality and safety standards are prioritized throughout manufacturing. The companys domain, scandbio.com, supports its activities in this field.
Scandbio has 1 investor. Key investors include LEAG.